Managed Account Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Managed Account Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$345M	Sell	5,840,397 -278,209	-5%	-$17.2M	0.28%	96
2015 Q1	$381M	Buy	6,118,606 +24,653	+0.4%	+$1.43M	0.34%	75
2014 Q4	$350M	Buy	6,093,953 +415,672	+7%	+$23.2M	0.35%	72
2014 Q3	$305M	Buy	5,678,281 +635,189	+13%	+$33.7M	0.34%	68
2014 Q2	$264M	Buy	5,043,092 +545,512	+12%	+$27.9M	0.32%	67
2014 Q1	$238M	Buy	4,497,580 +596,121	+15%	+$27.6M	0.31%	73
2013 Q4	$156M	Sell	3,901,459 -302,835	-7%	-$11.9M	0.21%	111
2013 Q3	$159M	Sell	4,204,294 -14,965	-0.4%	-$584K	0.23%	109
2013 Q2	$165M	Buy	+4,219,259	New	+$164M	0.26%	90

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Managed Account Advisors's TEVA Position: Q2 2015 in Review

Managed Account Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 4.5% in Q2 2015, selling an estimated $17.2M and leaving 5,840,397 shares worth $345M. The position accounts for 0.28% of the portfolio, ranked #96.

Managed Account Advisors first reported a position in TEVA in Q2 2013 and has held it in 9 quarters since. The position peaked at $381M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Managed Account Advisors held 5,840,397 shares of Teva Pharmaceuticals worth $345M as of Q2 2015.
Managed Account Advisors sold 278,209 Teva Pharmaceuticals shares in Q2 2015, an estimated $17.2M.
Teva Pharmaceuticals made up 0.28% of Managed Account Advisors's portfolio in Q2 2015, its #96 holding.
Managed Account Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Teva Pharmaceuticals position peaked at $381M in Q1 2015.
819 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.